X-ray diffraction from paclitaxel-loaded zwitterionic and cationic model membranes

Chemistry and Physics of Lipids

Volumn 150, Issue 1, 2007, Pages 58-65

  Cavalcanti, Leide P ^a   Konovalov, Oleg ^a   Haas, Heinrich ^b  

^a EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^b MediGene AG   (Germany)

Author keywords

Cancer; Cationic liposomes; Lipid membranes; Nanoparticles; Paclitaxel; Targeted drug delivery; X ray diffraction

Indexed keywords

PACLITAXEL;

ARTICLE; ARTIFICIAL MEMBRANE; CHEMICAL STRUCTURE; HUMIDITY; LIPID MEMBRANE; PRIORITY JOURNAL; SOLUBILITY; X RAY DIFFRACTION;

HYDROPHOBICITY; IONS; LIPID BILAYERS; LIPOSOMES; MODELS, BIOLOGICAL; PACLITAXEL; SOLUBILITY; X-RAY DIFFRACTION;

EID: 35148831087     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2007.06.219     Document Type: Article

References (32)

1. Adams J.D., Flora K.P., Goldspiel B.R., Wilson J.W., Arbuck S.G., and Finley R. Taxol: a history of pharmaceutical development and current pharmaceutical concerns. J. Natl. Cancer. Inst. Monogr. 15 (1993) 141-147
2. Balasubramanian S.V., and Straubinger R.M. Taxol-lipid interactions: Taxol-dependent effects on the physical properties of model membranes. Biochemistry 33 (1994) 8941-8947
3. Bernsdorff C., Reszka R., and Winter R. Interaction of the anticancer agent Taxol (paclitaxel) with phospholipid bilayers. J. Biomed Mater Res 46 (1999) 141-149
4. Caminiti R., Caracciolo G., Pisani M., and Bruni P. Effect of hydration on the long-range order of lipid multilayers investigated by in situ time-resolved energy dispersive X-ray diffraction. Chem. Phys. Lett. 409 4-6 (2005) 331-336
5. Campbell R.B., Balasubramanian S.V., and Straubinger R.M. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. J. Pharm Sci 90 8 (2001) 1091-1105
6. Cavalcanti L.P., Haas H., Bordallo H.N., Konovalov O., Gutberlet T., and Fragneto G. In situ X-ray and Neutron Diffraction Study of Lipid Membrane Swelling. Proceedings of the 'third Int. Workshop on Dynamics in Confinement' - Special Topics. Eur. Phys. J. 141 (2007) 217-221
7. Cavalcanti L.P., Konovalov O., Torriani I.L., and Haas H. Drug loading to lipid-based cationic nanoparticles. Nucl. Instrum. Meth. B 238 (2005) 290-293
8. Cavalcanti L.P., and Torriani I.L. Thermotropic phase behavior of DPPC liposome systems in the presence of the anti-cancer agent 'Ellipticine'. Eur. Biophys. J. 36 (2006) 67-71
9. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51 (1999) 691-744
10. Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 13 (1995) 527-537
11. Haas H. Development of new taxane formulations (article in german). Pharm. Unserer Zeit 34 (2005) 115-121
12. Hristova K., and White S.H. Determination of the hydrocarbon core structure of fluid dioleoylphosphocholine (DOPC) bilayers by x-ray diffraction using specific bromination of the double-bonds: effect of hydration. Biophys. J. 74 (1998) 2419-2433
13. Lasch J., Weissig V., and Brandl M. Preparation of liposomes. In: Torchilin V.P., and Weissig V. (Eds). Liposomes. second ed (2003), Oxford Univ Press, Oxford 3-29
14. Liggins R.T., Hunter W.L., and Burt H.M. Solid-state characterization of paclitaxel. J. Pharm. Sci. 86 (1997) 1458-1463
15. Michaelis U., and Haas H. Targeting of Cationic Liposomes to Endothelial Tissue. In: Gregoriadis G. (Ed). Liposome Technology Vol. III (2006) Chapter 13
16. Needham D., and Sarpal R.S. Binding of paclitaxel to lipid interfaces: correlations with interface compliance. J. Liposome Res. 8 2 (1998) 147-163
17. Nicolaou K.C., Dai W.M., and Guy R.K. Chemistry and biology of Taxol. Angew. Chem. Int. Edit. 33 (1994) 15-44
18. Nuijen B., Bouma M., Schellens H.M., and Beijnen J.H. Progress in the development of alternative pharmaceutical formulations of taxanes. Invest. New Drugs 19 (2001) 143-153
19. Petrache H.I., Tristram-Nagle S., Gawrisch K., Harries D., Adrian Parsegian V., and Nagle J.F. Structure and fluctuations of charged phosphatidylserine bilayers in the absence of salt. Biophys. J. 86 (2004) 1574-1586
20. Seydel J.K., and Wiese M. Drug-Membrane Interactions: Analysis, Drug Distribution, Modeling. In: Mannhold R., Kubinyi H., and Folkers G. (Eds). Methods and Principles in Medicinal Chemistry 15 (2002), Wiley, Weinheim
21. Sharma A., and Straubinger R.M. Novel Taxol formulations: preparation and characterization of Taxol containing liposomes. Pharm. Res. 11 (1994) 889-896
22. Singla A.K., Garg A., and Deepika A. Paclitaxel and its formulations. Int J. Pharm. 235 (2002) 179-192
23. Smilgies D.M., Boudet N., Struth B., and Konovalov O. Troika II: a versatile beamline for the study of liquid and solid interface. J. Synchrotron Radiat. 12 (2005) 329-339
24. Straubinger R.M., and Balasubramanian S.V. Preparation and characterization of taxane-containing liposomes. Methods Enzymol. 391 (2005) 97-117
25. Thurston G., McLean J.W., Rizen M., Baluk P., Haskell A., Murphy T.J., Hanahan D., and McDonald D.M. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Invest. 101 (1998) 1401-1413
26. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
27. Van Zuylen L., Verweij J., and Sparreboom A. Role of formulation vehicles in taxane pharmacology. Invest. New Drugs 19 (2001) 125-141
28. Wenk M.R., Fahr A., Reszka R., and Seelig J. Paclitaxel partitioning into lipid bilayers. J. Pharm. Sci. 85 (1996) 228-231
29. Wiener M.C., and White S.H. Structure of a fluid dioleoylphosphatidylcholine bilayer determined by joint refinement of x-ray and neutron diffraction data. II. Distribution and packing of terminal methyl groups. Biophys. J. 61 (1992) 428-433
30. Zantl R., Baicu L., Artzner F., Sprenger I., Rapp G., and Radler J.O. Thermotropic phase behavior of cationic lipid-DNA complexes compared to binary lipid mixtures. J. Phys. Chem. B 103 (1999) 10300-10310
31. Zhang J.A., Anyarambhatla G., Ma L., Ugwu S., Xuan T., Sardone T., and Ahmad I. Development and characterization of a novel Cremophor (R) EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur. J. Pharm. Biopharm. 59 (2005) 177-187
32. Zhao L., Feng S.-S., and Go M.L. Investigation of molecular interactions between paclitaxel and DPPC by Langmiur film balance and differential scanning calorimetry. J. Pharm. Sci. 93 (2004) 86-98